SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Eric Linsley to speak at CED's Biotech Forum: "How Early is Too Early?" in RTP, NC
News | 04. 28. 2008
